{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:30:50Z","timestamp":1793496650333,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"vor","delay-in-days":549,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["2014-SGR-383"],"award-info":[{"award-number":["2014-SGR-383"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["SLT 002\/16\/0043"],"award-info":[{"award-number":["SLT 002\/16\/0043"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["2017-SGR-1395"],"award-info":[{"award-number":["2017-SGR-1395"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010552","name":"Department of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010552","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010076","name":"Conseil R\u00e9gional Provence-Alpes-C\u00f4te d'Azur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014182","name":"Cancerop\u00f4le Provence-Alpes-C\u00f4te d\u2019Azur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014182","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007586","name":"Aix-Marseille Universit\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007586","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.exphem.2025.104748","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T11:21:09Z","timestamp":1740050469000},"page":"104748","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["D816V KIT mutation induces mitochondrial morphologic and functional changes through BNIP3 downregulation in human myeloid cell lines ROSA and TF-1"],"prefix":"10.1016","volume":"145","author":[{"given":"Sabina","family":"Cisa-Wieczorek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Isabel","family":"Hern\u00e1ndez-Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilde","family":"Parre\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan P.","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Bussaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maite","family":"Carricondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Ubeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Dubreuil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Zorzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Brenet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3399-346X","authenticated-orcid":false,"given":"Josep F.","family":"Nomdedeu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2025.104748_bib0001","first-page":"385","article-title":"The progress and implication of stem cell factor","volume":"22","author":"Chen","year":"2002","journal-title":"Basic Med Sci"},{"key":"10.1016\/j.exphem.2025.104748_bib0002","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1158\/0008-5472.CAN-16-2234","article-title":"Advances in the classification and treatment of mastocytosis: current status and outlook toward the future","volume":"77","author":"Valent","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2025.104748_bib0003","first-page":"920","article-title":"KIT activating mutations: incidence in adult and pediatric acute myeloid leukemia, and identification of an internal tandem duplication","volume":"89","author":"Beghini","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2025.104748_bib0004","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1200\/JCO.2004.05.140","article-title":"Biology of gastrointestinal stromal tumors","volume":"22","author":"Corless","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2025.104748_bib0005","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1200\/JCO.2006.06.2984","article-title":"Somatic activation of KIT in distinct subtypes of melanoma","volume":"24","author":"Curtin","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2025.104748_bib0006","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/S0002-9440(10)65419-3","article-title":"Activating c-kit gene mutations in human germ cell tumors","volume":"154","author":"Tian","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.exphem.2025.104748_bib0007","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1172\/JCI116761","article-title":"Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product","volume":"92","author":"Furitsu","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2025.104748_bib0008","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1182\/blood.V88.3.995.995","article-title":"Neoplastic transformation of normal hematopoietic cells by constitutively activating mutations of c-kit receptor tyrosine kinase","volume":"88","author":"Kitayama","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.104748_bib0009","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1517\/13543784.2013.740010","article-title":"Therapeutic targeting of c-KIT in cancer","volume":"22","author":"Ashman","year":"2013","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.exphem.2025.104748_bib0010","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2025.104748_bib0011","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.trecan.2016.06.002","article-title":"Oncogene-directed alterations in cancer cell metabolism","volume":"2","author":"Nagarajan","year":"2016","journal-title":"Trends Cancer"},{"key":"10.1016\/j.exphem.2025.104748_bib0012","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/jcp.1041400219","article-title":"Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin","volume":"140","author":"Kitamura","year":"1989","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.exphem.2025.104748_bib0013","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1182\/blood-2013-10-534685","article-title":"A new human mast cell line expressing a functional IgE receptor converts to tumorigenic growth by KIT D816V transfection","volume":"124","author":"Saleh","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.104748_bib0014","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1182\/blood-2014-08-594408","article-title":"AML cells have low spare reserve capacity in their respiratory chain that renders them susceptible to oxidative metabolic stress","volume":"125","author":"Sriskanthadevan","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.104748_bib0015","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.jaci.2011.02.005","article-title":"Human mast cell degranulation and preformed TNF secretion require mitochondrial translocation to exocytosis sites: relevance to atopic dermatitis","volume":"127","author":"Zhang","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.exphem.2025.104748_bib0016","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"10.1016\/j.exphem.2025.104748_bib0017","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.cell.2008.08.021","article-title":"Cancer cell metabolism: Warburg and beyond","volume":"134","author":"Hsu","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2025.104748_bib0018","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1113\/jphysiol.2003.049478","article-title":"Mitochondrial formation of reactive oxygen species","volume":"552","author":"Turrens","year":"2003","journal-title":"J Physiol"},{"key":"10.1016\/j.exphem.2025.104748_bib0019","doi-asserted-by":"crossref","first-page":"R170","DOI":"10.1016\/j.cub.2018.01.004","article-title":"Mitophagy and quality control mechanisms in mitochondrial maintenance","volume":"28","author":"Pickles","year":"2018","journal-title":"Curr Biol"},{"key":"10.1016\/j.exphem.2025.104748_bib0020","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1161\/CIRCRESAHA.112.265819","article-title":"Mitochondria and mitophagy: the yin and yang of cell death control","volume":"111","author":"Kubli","year":"2012","journal-title":"Circ Res"},{"key":"10.1016\/j.exphem.2025.104748_bib0021","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2025.104748_bib0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.hemonc.2016.08.005","article-title":"Prognostic importance of c-kit mutations in core binding factor acute myeloid leukemia: a systematic review","volume":"10","author":"Ayatollahi","year":"2017","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"10.1016\/j.exphem.2025.104748_bib0023","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1182\/blood-2013-08-518886","article-title":"Clinical and biological implications of driver mutations in myelodysplastic syndromes","volume":"122","author":"Papaemmanuil","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.104748_bib0024","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/cdd.2009.16","article-title":"Role of BNIP3 and NIX in cell death, autophagy, and mitophagy","volume":"16","author":"Zhang","year":"2009","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.exphem.2025.104748_bib0025","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41580-019-0199-y","article-title":"mTOR at the nexus of nutrition, growth, ageing and disease","volume":"21","author":"Liu","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.exphem.2025.104748_bib0026","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nchembio.1712","article-title":"Targeting mitochondria metabolism for cancer therapy","volume":"11","author":"Weinberg","year":"2015","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.exphem.2025.104748_bib0027","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1111\/j.1742-4658.2007.05686.x","article-title":"Energy metabolism in tumor cells","volume":"274","author":"Moreno-S\u00e1nchez","year":"2007","journal-title":"FEBS J"},{"key":"10.1016\/j.exphem.2025.104748_bib0028","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.ccr.2011.10.015","article-title":"Inhibition of mitochondrial translation as a therapeutic strategy for human acute myeloid leukemia","volume":"20","author":"Skrti\u0107","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2025.104748_bib0029","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/2426712","article-title":"Targeting mitochondrial bioenergetics as a therapeutic strategy for chronic lymphocytic leukemia","volume":"2018","author":"Roy Chowdhury","year":"2018","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.exphem.2025.104748_bib0030","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.neo.2017.07.004","article-title":"The stromal microenvironment modulates mitochondrial oxidative phosphorylation in chronic lymphocytic leukemia cells","volume":"19","author":"Vangapandu","year":"2017","journal-title":"Neoplasia"},{"key":"10.1016\/j.exphem.2025.104748_bib0031","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1038\/leu.2017.45","article-title":"ITD mutation in FLT3 tyrosine kinase promotes Warburg effect and renders therapeutic sensitivity to glycolytic inhibition","volume":"31","author":"Ju","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2025.104748_bib0032","doi-asserted-by":"crossref","first-page":"18859","DOI":"10.1038\/s41598-019-55211-w","article-title":"Mutant IDH1 confers resistance to energy stress in normal biliary cells through PFKP-induced aerobic glycolysis and AMPK activation","volume":"9","author":"Fujiwara","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.exphem.2025.104748_bib0033","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.biocel.2004.09.010","article-title":"Mitochondrial biogenesis and mitochondrial DNA maintenance of mammalian cells under oxidative stress","volume":"37","author":"Lee","year":"2005","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.exphem.2025.104748_bib0034","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/0891-5849(94)00209-3","article-title":"Reactions of oxyl radicals with DNA","volume":"18","author":"Breen","year":"1995","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.exphem.2025.104748_bib0035","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0021-9258(18)48474-8","article-title":"8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G\u2014-T and A\u2014-C substitutions","volume":"267","author":"Cheng","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2025.104748_bib0036","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1477-3163-5-14","article-title":"Reactive oxygen species: role in the development of cancer and various chronic conditions","volume":"5","author":"Waris","year":"2006","journal-title":"J Carcinog"},{"key":"10.1016\/j.exphem.2025.104748_bib0037","doi-asserted-by":"crossref","first-page":"855","DOI":"10.4161\/auto.6.7.13005","article-title":"Bnip3-mediated mitochondrial autophagy is independent of the mitochondrial permeability transition pore","volume":"6","author":"Quinsay","year":"2010","journal-title":"Autophagy"},{"key":"10.1016\/j.exphem.2025.104748_bib0038","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1128\/MCB.00166-09","article-title":"Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains","volume":"29","author":"Bellot","year":"2009","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.exphem.2025.104748_bib0039","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/cdd.2010.146","article-title":"Bnip3 impairs mitochondrial bioenergetics and stimulates mitochondrial turnover","volume":"18","author":"Rikka","year":"2011","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.exphem.2025.104748_bib0040","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1128\/MCB.00167-12","article-title":"BNip3 regulates mitochondrial function and lipid metabolism in the liver","volume":"32","author":"Glick","year":"2012","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.exphem.2025.104748_bib0041","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/sj.cdd.4400810","article-title":"Hypoxia induces the expression of the pro-apoptotic gene BNIP3","volume":"8","author":"Guo","year":"2001","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.exphem.2025.104748_bib0042","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/path.1486","article-title":"Expression of the cell death genes BNip3 and NIX in ductal carcinoma in situ of the breast; correlation of BNip3 levels with necrosis and grade","volume":"201","author":"Sowter","year":"2003","journal-title":"J Pathol"},{"key":"10.1016\/j.exphem.2025.104748_bib0043","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/1471-2407-9-175","article-title":"Expression of BNIP3 in invasive breast cancer: correlations with the hypoxic response and clinicopathological features","volume":"9","author":"Koop","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1016\/j.exphem.2025.104748_bib0044","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1038\/sj.onc.1208642","article-title":"Loss of BNIP3 expression is a late event in pancreatic cancer contributing to chemoresistance and worsened prognosis","volume":"24","author":"Erkan","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2025.104748_bib0045","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/cdd.2008.185","article-title":"The role of Bcl-2 family member BNIP3 in cell death and disease: NIPping at the heels of cell death","volume":"16","author":"Burton","year":"2009","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.exphem.2025.104748_bib0046","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.cell.2016.07.002","article-title":"Mitochondria and cancer","volume":"166","author":"Vyas","year":"2016","journal-title":"Cell."},{"key":"10.1016\/j.exphem.2025.104748_bib0047","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1182\/blood.V120.21.1708.1708","article-title":"BNIP3 is downregulated in myelodysplastic syndromes and acute myeloid leukemia and is a potential molecular target for decitabine","volume":"120","author":"Lazarini","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.104748_bib0048","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/sj.bjc.6602422","article-title":"Aberrant DNA methylation associated with silencing BNIP3 gene expression in haematopoietic tumours","volume":"92","author":"Murai","year":"2005","journal-title":"Br J Cancer"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X25000396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X25000396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:24:02Z","timestamp":1793496242000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X25000396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":48,"alternative-id":["S0301472X25000396"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2025.104748","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"D816V KIT mutation induces mitochondrial morphologic and functional changes through BNIP3 downregulation in human myeloid cell lines ROSA and TF-1","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2025.104748","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society for Experimental Hematology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104748"}}